EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 310 full-time employees. The firm's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. The company specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. The company also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
How did EDAP's recent EPS compare to expectations?
The most recent EPS for Edap TMS SA is $, expectations of $.
How did Edap TMS SA EDAP's revenue perform in the last quarter?
Edap TMS SA revenue for the last quarter is $
What is the revenue estimate for Edap TMS SA?
According to of Wall street analyst, the revenue estimate of Edap TMS SA range from $ to $
What's the earning quality score for Edap TMS SA?
Edap TMS SA has a earning quality score of A-/63.872482. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Edap TMS SA report earnings?
Edap TMS SA next earnings report is expected in
What are Edap TMS SA's expected earnings?
Edap TMS SA expected earnings is $, according to wall-street analysts.